TruBridge Inc
TruBridge operates with a debt-to-equity ratio of 1.0, indicating a balanced capital structure, while its current ratio of 1.95 suggests moderate liquidity. The company's price-to-book ratio of 2.1 and price-to-tangible-book ratio of 2.1 reflect a market valuation that is slightly above book value, but its negative return on equity (-1.0%) and return on assets (-0.45%) indicate poor profitability relative to its capital base. The company's operating income of $662,000 is modest compared to its revenue of $84.1 million, and its net income is negative at -$1.85 million, signaling financial strain. The enterprise value to EBITDA ratio of 858.41 is extremely high, suggesting that the company is overvalued relative to its earnings, while the enterprise value to revenue ratio of 6.76 is in line with industry norms. TruBridge's revenue is concentrated in a single business segment, with no disclosed geographic diversification, which increases exposure to sector-specific risks. The company's capital expenditures of -$5.02 million indicate a reduction in investment in long-term assets, which may affect future growth. Looking ahead, the company is expected to maintain a flat revenue trajectory, with no significant growth anticipated in the next fiscal year. Analysts have assigned a mean price target of $25.67, with a median of $26.25, suggesting limited upside potential. The company faces moderate liquidity risk due to negative free cash flow of -$601,000 and negative operating cash flow of -$2.08 million, which could constrain its ability to fund operations without external financing. While dilution risk is currently low, the company's negative net cash position after subtracting total debt raises concerns about its financial flexibility. Recent filings and transcripts have not disclosed any material events that would significantly alter the company's financial outlook, and no major strategic shifts have been reported.
Business. TruBridge Inc provides healthcare equipment and technology solutions, primarily serving the healthcare services and equipment sector.
Classification. TruBridge is classified under the Healthcare sector, specifically in the Advanced Medical Equipment & Technology industry, with a confidence level of 0.92.
- TruBridge has a balanced capital structure but faces liquidity challenges due to negative free and operating cash flows.
- The company's profitability metrics are weak, with negative returns on equity and assets.
- Revenue is concentrated in a single segment, increasing exposure to sector-specific risks.
- Analysts project limited upside, with a mean price target of $25.67 and a median of $26.25.
- The company's high EV/EBITDA ratio suggests overvaluation relative to earnings.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.